Lisa West, MD
Gynecology · Midlothian, VANPI 1346220290
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,569 of the $20,245 with a category attached, or 62.1%. 33 manufacturers reported payments, led by AbbVie at 38.5% of the total. Reporting peaked in 2019 at $7,934 and has fallen 84.2% since, to $1,256 in 2025. Among gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $47.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- AMAG Pharmaceuticals, Inc.$7K
- Novo Nordisk$806
- Astellas Pharma US Inc$670
- Pfizer$415
- Lilly USA, LLC$409
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$12,56962%
- Travel & lodging$2851%
- Food & beverage$7,17435%
- Education$2161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 150 | $7,801 |
| AMAG Pharmaceuticals, Inc. | 20 | $7,322 |
| Novo Nordisk | 38 | $806 |
| Astellas Pharma US Inc | 38 | $670 |
| Pfizer | 22 | $415 |
| Lilly USA, LLC | 10 | $409 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $326 |
| Intuitive Surgical | 4 | $272 |
| Myovant Sciences Inc. | 9 | $240 |
| Exeltis, USA Inc. | 14 | $234 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $167 |
| Therapeuticsmd, Inc. | 11 | $165 |
| Biohaven Pharmaceuticals, Inc. | 7 | $162 |
| Mayne Pharma Commercial LLC | 9 | $140 |
| Radius Health, Inc. | 6 | $122 |
| Amgen | 6 | $112 |
| Sumitomo Pharma America, Inc. | 5 | $112 |
| Organon | 5 | $101 |
| Millicent US Inc | 4 | $76 |
| Avion Pharmaceuticals | 5 | $75 |
| Scynexis, Inc. | 5 | $70 |
| Conmed Corporation | 1 | $67 |
| Ardelyx, Inc. | 4 | $64 |
| Lupin Inc. | 3 | $46 |
| Mycovia Pharmaceuticals, Inc. | 3 | $45 |
| Evofem Biosciences, Inc. | 3 | $44 |
| Kvk-tech, Inc. | 6 | $43 |
| Merck | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Duchesnay USA Incorporated | 1 | $20 |
| Coopersurgical, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,245 in reported general payments places this provider in the 95th percentile of 71 gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 83 | $6,055 |
| PremarinEstrogens, Conjugated | 14 | $3,097 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 36 | $842 |
| Estradiol (Once Weekly)Estradiol | 14 | $706 |
| ValacyclovirValacyclovir Hcl | 19 | $637 |
| ProgesteroneProgesterone, Micronized | 12 | $414 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $191 |
| Fluconazole | 42 | $189 |
| Nystatin | 13 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $415 | $3,09714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 gynecology providers in Virginia.
Other gynecology in Midlothian
- Jennifer ShoemakerMidlothian$4K
- Keith BerkleMechanicsville$170K
- Mariel FocseneanuNewport News$34K
- Laura HomewoodCharlottesville$27K
- Sima BinaReston$9K
- Elizabeth BrunnArlington$6K
- Stacy LahtiDanville$4K
- Sarah WoodsLynchburg$3K
- Gregory MooreRichmond$3K
- Charlie FaulkNewport News$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.